Evidence map›Paper›PMID 36511370›Full record

ArticleThe British journal of surgery2023

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.

Aki Uutela, Arno Nordin, Emerik Osterlund, Päivi Halonen, Raija Kallio, Leena-Maija Soveri, Tapio Salminen, Annika Ålgars, Ari Ristimäki, Ali Ovissi and 16 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The British journal of surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Aki UutelaDepartment of Transplantation and Liver Surgery, Abdominal Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID 0000-0003-1324-5894
Arno NordinDepartment of Transplantation and Liver Surgery, Abdominal Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Emerik OsterlundDepartment of Transplantation and Liver Surgery, Abdominal Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Päivi HalonenDepartment of Oncology, Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland.
Raija KallioDepartment of Oncology, Oulu University Hospital, Oulu, Finland.
Leena-Maija SoveriHome Care Geriatric Clinic and Palliative Care, Joint Municipal Authority for Health Care and Social Services in Keski-Uusimaa, Hyvinkää, Finland.
Tapio SalminenDepartment of Oncology, Tampere University Hospital and University of Tampere, Tampere, Finland.
Annika ÅlgarsDepartment of Oncology, Turku University Hospital and University of Turku, Turku, Finland.
Ari RistimäkiDepartment of Pathology, HUS Diagnostic Centre and Applied Tumour Genomics, Research Programmes Unit, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Ali OvissiDepartment of Radiology, HUS Medical Imaging Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Annamarja LamminmäkiDepartment of Oncology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.
Timo MuhonenFaculty of Medicine, University of Helsinki, Helsinki, Finland.
Juha KononenDepartment of Oncology, Central Finland Hospital Nova, Jyväskylä, Finland.
Raija RistamäkiDepartment of Oncology, Turku University Hospital and University of Turku, Turku, Finland.
Eetu HeerväDepartment of Oncology, Turku University Hospital and University of Turku, Turku, Finland.
Hanna StedtDepartment of Oncology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.
Kaisa LehtomäkiDepartment of Oncology, Tampere University Hospital and University of Tampere, Tampere, Finland.
Soili KytöläDepartment of Genetics, HUSLAB, HUS Diagnostic Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Jari SundströmDepartment of Pathology, Turku University Hospital and University of Turku, Turku, Finland.
Markus J MäkinenDepartment of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland.
Lasse NieminenDepartment of Pathology, Tampere University Hospital and University of Tampere, Tampere, Finland.
Teijo KuopioDepartment of Pathology, Central Finland Central Hospital, Jyväskylä, Finland.
Mauri KeinänenDepartment of Genetics, FIMLAB laboratories, Tampere University Hospital, Tampere, Finland.
Pia OsterlundDepartment of Oncology, Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland.
Helena IsoniemiDepartment of Transplantation and Liver Surgery, Abdominal Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID 0000-0001-6184-3405
RAXO Study Group

Funding

Cancer Foundation FinlandFinska LäkaresällskapetHelsinki University HospitalRelander's FoundationTampere University Hospital Funds
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsLiver NeoplasmsHepatectomyHumansMutationProspective StudiesProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)BRAF protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)

Identifiers

PMID36511370
PMCPMC10361677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.